key: cord-0683269-e4twdivu
authors: Yoo, Hae Won; Shin, Jae Il; Yon, Dong Keon; Lee, Seung Won
title: COVID-19 morbidity and severity in patients with non-alcoholic fatty liver disease in South Korea: a nationwide cohort study
date: 2021-07-24
journal: Clin Gastroenterol Hepatol
DOI: 10.1016/j.cgh.2021.07.031
sha: 6aec0383180282d22d79a1aeba7762397e9f75c3
doc_id: 683269
cord_uid: e4twdivu

nan

to COVID-19, including infectivity and disease-related outcomes. 41 We conducted a population-based nationwide cohort study using data from the Korean Patients were classified into three groups. Pre-existing NAFLD was defined when patients met one of the following criteria: (1) hepatic steatosis index (HSI) ≥36, (2) fatty liver index

Clinical Features of COVID-19-Related Liver Functional 114

Hepatobiliary Adverse Drug Reactions Associated 116 With Remdesivir: The WHO International Pharmacovigilance Study

Autoimmune inflammatory rheumatic diseases and 119

COVID-19 outcomes in South Korea: a nationwide cohort study

Hospitalization costs and risk of mortality in 122 adults with nonalcoholic steatohepatitis: Analysis of a French national hospital database

Proton pump inhibitors and the risk of severe COVID-125 19: a post-hoc analysis from the Korean nationwide cohort

Severe clinical outcomes of COVID-19 associated 127 with proton pump inhibitors: a nationwide cohort study with propensity score matching